Physicians as gatekeepers in the use of medical Marijuana

Journal of the American Academy of Psychiatry and the Law

Volumn 39, Issue 4, 2011, Pages 460-464

  Thompson, John W ^a   Koenen, Mark A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

EDITORIAL; HUMAN; LEGAL ASPECT; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PHYTOTHERAPY; UNITED STATES;

CANNABIS; GATEKEEPING; HUMANS; PHYSICIAN'S ROLE; PHYTOTHERAPY; UNITED STATES;

EID: 84856856915     PISSN: 10936793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (33)

1. California Health and Safety Code § 11362.5 (1996)
2. California Health and Safety Code § 11362.5(A) (1996)
3. Gonzales v. Raich, 545 U.S. 1 (2005)
4. American Society of Addiction Medicine: The Role of the Physician in "Medical" Marijuana. Bethesda, MD: ASAM, September 2010
5. Meiri E, Jhangiani H, Vredenburgh JJ, et al: Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting (CINV). J Clin Oncol 23:8018, 2005
6. Lynch ME, Campbell F: Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials. Br J Clin Pharmacol 72:734-744, 2011
7. Grant JE, Odlaug BL, Chamberlin SR, et al: Dronabinol, a cannabinoid agonist, reduces trichotillomania: a pilot study. Psychopharmacology (Berl), in press
8. Sastre-Garriga J, Vila C, Clissold S, et al: THC and CBD oromucosal spray in the management of spasticity associated with multiple sclerosis. Expert Rev Neurother 11:627-637, 2011
9. Strasser F, Luftner D, Possinger K, et al: Comparison of orally administered cannabis extract and delta-9 tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III randomized double blind-pla- cebo, controlled clinical trial from the Cannabis-In-Cachexia- Study Group. J Clin Oncol 24:3394-3400, 2006
10. Buggy DJ, Toogood L, Maric S, et al: Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain. Pain 106:169-172, 2003
11. Green K: Marijuana smoking vs. cannabinoids for glaucoma therapy. Arch Ophthalmol 116:1433-1437, 1998
12. Wang T, Collet JP, Shapiro S, et al: Adverse effects of medical cannabinoids: a systematic review. CMAJ 178:1669-1678, 2008
13. Schweinsburg AD, Brown SA, Tapert SF: The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev 1:99-111, 2008
14. Joy JE, Watson SJ, Benson JA, eds: Marijuana and Medicine: Assessing the Science Base. Washington, DC: National Academy Press, 1999
15. Peralta V, Cuesta MJ: Influence of cannabis abuse on schizophrenic psychopathology. Acta Scand Psychiatr 85:127-130, 1992
16. Jons A: Psychiatric effects of cannabis. Br J Psychiatry 178:116-122, 2001
17. Wu TC, Tashkin DP, Djahed B, et al: Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 318:347-351, 1988
18. Bloor RN, Wang TS, Spanel P, et al: Ammonia release from heated 'street' cannabis leaf and its potential toxic effects on cannabis users. Addiction 103:1671-1677, 2008
19. di Forti M, Morgan C, Dazzan P, et al: High-potency cannabis and the risk of psychosis. Br J Psychiatry 195:488-491, 2009
20. McPartland JM. Contaminants and adulterants in herbal cannabis, in Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential. New York: Hayworth Press, 2002
21. Judge orders Eagle Rock dispensary to stop selling medical marijuana. Los Angeles Times. January 30, 2010. Available at www.latimesblogs.latimes.com/lanow/2010/01/judge-orders-eaglerock-dispensary-to-stop-selling-medical-marijuana.html. Accessed September 7, 2011
22. Belle-Isle L, Hathaway A: Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care 19:500-506, 2007
23. 21 U.S. Code § 13 (2010)
24. American Society of Addiction Medicine. The Role of the Physician in "Medical" Marijuana. Bethesda, MD: ASAM, September 16, 2010
25. Okie S: Medical marijuana and the Supreme Court. N Engl J Med 353:648-651, 2005
26. Johnson G: Agents raid Wash. medical marijuana dispensaries. Seattle Times. April 28, 2011. Available at http://www.seattletimes.com. Accessed September 7, 2011
27. Veto message by Governor Gregoire dated April 29, 2011 regarding an act relating to medical use of cannabis. Available at http://www.governor.wa.gov/billaction/2011/veto/5073.pdf. Accessed September 8, 2011
28. http://www.letfreedomgrow.com/. Arch Cape, OR: American Alliance for Medical Cannabis. Accessed September 8, 2011
29. Russo EB: Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment resistant conditions? Neuro Endocrinol Lett 29:192-200, 2008
30. O'Connell TJ, Bou-Matar CB: Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Red J 4:16, 2007
31. Thurstone C, Lieberman SA, Schmiege SJ: Medical marijuana diversion and associated problems in adolescent substance treatment. Drug Alcohol Depend 118:489-492, 2011
32. American Society of Addiction Medicine. The Role of the Physician in "Medical" Marijuana. Bethesda, MD: ASAM, September 4-5, 2010
33. Study: marijuana prices to crater if legalized. Cannabis News. Available at http://www.cannabisnews.org/united-states-cannabis-news/study-marijuana-prices-to-crater-if-legalized/. Accessed September 8, 2011